Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 12, 2005, Pages 1418-1421

  Bernier, Marie Odile ^a   Morel, Olivier ^a   Rodien, Patrice ^b   Muratet, Jean Pierre ^c   Giraud, Philippe ^a   Rohmer, Vincent ^b   Jeanguillaume, Christian ^a   Bigorgne, Jean Claude ^b   Jallet, Pierre ^a  

^a CENTRE PAUL PAPIN   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c CENTRE JEAN BERNARD   (France)

Author keywords

Radioiodine therapy; Thyroglobulin; Thyroid cancer

Indexed keywords

IODINE 131; LEVOTHYROXINE; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; CANCER INVASION; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; DRUG UPTAKE; FEMALE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; RADIOIMMUNOTHERAPY; RADIOISOTOPE THERAPY; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS; THYROID NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 28544452175     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1866-0     Document Type: Review

References (18)

1. Schlumberger MJ. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 1999;22 (11 Suppl):3-7
2. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000;7:229-39
3. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63
4. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000;85:175-8
5. Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002;87:1490-8
6. 131I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 2004;45:988-94
7. 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid 2004;14:301-6
8. Roelants V, Nayer PD, Bouckaert A, Beckers C. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24:722-7
9. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003;88:1107-11
10. Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999;26:1448-52
11. Hall FT, Beasley NJ, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope 2003;113:77-81
12. Muratet JP, Giraud P, Daver A, Minier JF, Gamelin E, Larra F. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med 1997;38:1362-8
13. Cramp WA, Yatvin MB, Harms-Ringdahl M. Recent developments in the radiobiology of cellular membranes. Acta Oncol 1994;33:945-52
14. Ramakrishnan N, McClain DE, Catravas GN. Membranes as sensitive targets in thymocyte apoptosis. Int J Radiat Biol 1993;63:693-7
15. Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nucl Med 1996;37:1962-4
16. Lin JD, Huang MJ, Hsu BR, Chao TC, Hsueh C, Liu FH, et al. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J Surg Oncol 2002;80:45-51
17. Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998;39:1542-6
18. Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. J Endocrinol Invest 2002;25:110-5